Lilac Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Lilac Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones (NCT06932146) | Lilac Therapeutics, Inc. | 2025-03-23 |
Track Lilac Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.